Association between Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) Polymorphisms and Nonalcoholic Fatty Liver Disease: A HuGE Review and Meta-Analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Xu, Renfan ^a   Tao, Anyu ^a   Zhang, Shasha ^a   Deng, Youbin ^a   Chen, Guangzhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; HUMAN; META ANALYSIS; NONALCOHOLIC FATTY LIVER;

CASE-CONTROL STUDIES; HUMANS; LIPASE; MEMBRANE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, GENETIC;

EID: 84925260735     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09284     Document Type: Article

References (47)

1. Angulo, P. Nonalcoholic fatty liver disease. N Engl J Med 346, 1221-1231 (2002).
2. Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395 (2004).
3. Farrell, G. C. & Larter, C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112 (2006).
4. Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53, 372-384 (2010).
5. Powell, E. E. et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74-80 (1990).
6. Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34, 274-285 (2011).
7. Musso, G., Gambino, R., Cassader, M. & Pagano, G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 52, 79-104 (2010).
8. Wilfred de Alwis, N. M. & Day, C. P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis 27, 44-54 (2007).
9. Miele, L. et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282-291 e281 (2008).
10. Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40, 1461-1465 (2008).
11. Day, C. P.&James, O. F. Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845 (1998).
12. Kotronen, A. et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52, 1056-1060 (2009).
13. Sookoian, S. & Pirola, C. J. PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease. World J Gastroenterol 18, 6018-6026 (2012).
14. Sookoian, S. & Pirola, C. J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883-1894 (2011).
15. Santoro, N. et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52, 1281-1290 (2010).
16. Valenti, L. et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52, 1274-1280 (2010).
17. Verrijken, A. et al. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring) 21, 2138-2145 (2013).
18. Kitamoto, T. et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet 132, 783-792 (2013).
19. Sookoian, S. et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 50, 2111-2116 (2009).
20. Thakkinstian, A. et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162, 201-211 (2005).
21. Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A. & Attia, J. The choice of a genetic model in the meta-analysis of molecular association studies. International journal of epidemiology 34, 1319-1328 (2005).
22. Zintzaras, E. & Lau, J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. Journal of clinical epidemiology 61, 634-645 (2008).
23. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558 (2002).
24. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-188 (1986).
25. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).
26. Kantartzis, K. et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58, 2616-2623 (2009).
27. Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209-1217 (2010).
28. Rotman, Y. et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894-903 (2010).
29. Speliotes, E. K. et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52, 904-912 (2010).
30. Petit, J. M. et al. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. Liver Int 31, 1332-1336 (2011).
31. Valenti, L. et al. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol 12, 111 (2012).
32. Guichelaar, M. M. et al. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. Obesity (Silver Spring) 21, 1935-1941 (2013).
33. Lin, Y. C. et al. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr 158, 740-744 (2011).
34. Hotta, K. et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet 11, 172 (2010).
35. Wang, C. W. et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int 31, 1326-1331 (2011).
36. Zain, S. M. et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum Genet 131, 1145-1152 (2012).
37. Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One 7, e38322 (2012).
38. Li, Y., Xing, C., Tian, Z. & Ku, H. C. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. BMC Med Genet 13, 113 (2012).
39. Peng, X. E. et al. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS One 7, e50256 (2012).
40. Lin, Y. C., Chang, P. F., Chang, M. H. & Ni, Y. H. A common variant in the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene is associated with nonalcoholic fatty liver disease in obese children. The American journal of clinical nutrition 97, 326-331 (2013).
41. Goran, M. I. et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 59, 3127-3130 (2010).
42. Musso, G., Bo, S., Cassader, M., De Michieli, F. & Gambino, R. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. The American journal of clinical nutrition 98, 895-906 (2013).
43. Lin, Y. C., Chang, P. F., Chang, M. H. & Ni, Y. H. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. The American journal of clinical nutrition 99, 869-874 (2014).
44. Niu, T. H. et al. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. World J Gastroenterol 20, 3655-3662 (2014).
45. Lee, S. S. et al. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Digestive diseases and sciences 59, 2967-2974 (2014).
46. Chen, W., Chang, B., Li, L. & Chan, L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52, 1134-1142 (2010).
47. Daly, A. K., Ballestri, S., Carulli, L., Loria, P. & Day, C. P. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 5, 253-263 (2011).